ArticleFrontiers in oncology2022

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment.

Changqing Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.